Cowen & Co
http://www.cowen.com/default.htmlCowen and Company offers investment banking services, including equity research, equity and convertible debt financings, mergers and acquisitions advisory services, and restricted security sales.
-
Editas Medicine (EDIT) Prices 12.5M Share Offering at $10/sh
-
Editas Medicine Announces Pricing of Offering of Common Stock
-
Editas Medicine (EDIT) Announces $125M Offering of Common Stock
-
Editas Medicine Announces Offering of Common Stock
-
Editas Medicine Announces Fourth Quarter and Full Year 2022 Results and Business Updates
-
Editas Medicine Announces Fourth Quarter and Full Year 2022 Results and Business Updates
-
Editas Medicine Announces Fourth Quarter and Full Year 2021 Results and Business Updates
-
Editas Medicine Announces Fourth Quarter and Full Year 2021 Results and Business Updates
-
Pre-Open Stock Movers 09/10: (ISEE) (AFRM) (SANW) Higher; (APLS) (COOK) (SUMO) Lower (more...)
-
After-Hours Stock Movers 09/09: (ISEE) (AFRM) (KPLT) Higher; (APLS) (COOK) (ZUMZ) Lower (more...)
-
Editas Medicine Announces Fourth Quarter and Full Year 2020 Results and Update
-
Editas Medicine Announces Fourth Quarter and Full Year 2020 Results and Update
-
Editas Medicine (EDIT) Prices 3.5M Share Common Offering at $66/Sh
-
Editas Medicine Announces Pricing of Offering of Common Stock
-
Editas Medicine Announces Pricing of Offering of Common Stock
-
Editas Medicine (EDIT) Announces 3.5M Share Offering of Common Stock
-
Editas Medicine Announces Offering of Common Stock
-
Editas Medicine Announces Offering of Common Stock
-
Editas Medicine Announces Fourth Quarter and Full Year 2019 Results and Update
-
Editas Medicine Announces Fourth Quarter and Full Year 2019 Results and Update
-
Editas Medicine Announces Fourth Quarter and Full Year 2018 Results and Update
-
Editas Medicine Announces Fourth Quarter and Full Year 2018 Results and Update
-
Editas Medicine (EDIT) Program Remains on Track Despite CEO Departure - Cowen
-
Editas Medicine Announces Fourth Quarter and Full Year 2017 Results and Update
-
Editas Medicine Announces Fourth Quarter and Full Year 2017 Results and Update
-
Editas Medicine (EDIT) Prices 4M Shares at $22.50
-
Editas Medicine, Inc. Announces Pricing of $90 Million Offering of Common Stock
-
Editas Medicine (EDIT) to Offer 4M Shares
-
Editas Medicine, Inc., Announces Proposed Offering of Common Stock
-
Editas Medicine to Present at Investor Conferences in March
-
Editas Medicine to Present at Cowen and Company 36th Annual Health Care Conference
-
Cowen Starts Editas Medicine (EDIT) at Outperform
-
Editas Medicine Announces Closing of Initial Public Offering and Full Exercise of Option to Purchase Additional Shares
-
Editas Medicine (EDIT) IPO Opens Flat
-
Editas Medicine Announces Pricing of Initial Public Offering
-
Editas Medicine (EDIT) Prices First IPO of 2016

